NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CFO Jay Matushak sold 4,970 shares of the stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $36,430.10. Following the sale, the chief financial officer now directly owns 17,747 shares of the company’s stock, valued at approximately $130,085.51. This represents a 21.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
NeueHealth Stock Up 0.7 %
Shares of NYSE NEUE traded up $0.05 during mid-day trading on Wednesday, hitting $7.45. 38,124 shares of the company traded hands, compared to its average volume of 70,685. NeueHealth, Inc. has a 1 year low of $3.79 and a 1 year high of $16.59. The stock has a market capitalization of $61.72 million, a price-to-earnings ratio of -0.15 and a beta of 0.57. The business has a 50 day moving average of $5.47 and a two-hundred day moving average of $5.38.
Institutional Trading of NeueHealth
A number of hedge funds have recently bought and sold shares of the company. NEA Management Company LLC acquired a new stake in shares of NeueHealth in the second quarter worth $14,834,000. Deer Management Co. LLC acquired a new position in NeueHealth during the second quarter valued at $5,436,000. Partners Group Holding AG purchased a new stake in NeueHealth in the 3rd quarter worth about $463,000. Finally, Renaissance Technologies LLC acquired a new stake in NeueHealth during the 2nd quarter worth about $312,000. 63.88% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on NEUE
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Read More
- Five stocks we like better than NeueHealth
- 3 Fintech Stocks With Good 2021 Prospects
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Using the MarketBeat Dividend Tax Calculator
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- How Can Investors Benefit From After-Hours Trading
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.